Ask Warren

S.Biomedics

304360 · KOSDAQ · ₩304360 · 에스바이오메딕스

₩20,150▼ ₩50 (0.25%)End-of-day · Oct 28, 2026 · End-of-day prices.
Trade
Alert me
SellBuy
AnnualQuarterly

Income statement

202520242023
Revenue₩17B₩14B₩13B
Cost of sales₩9B₩7B₩6.6B
Gross profit₩7.5B₩6.7B₩6.6B
Operating income−₩8.3B−₩5.4B−₩6B
Net income−₩7.1B−₩5.8B−₩6.5B
Net income to shareholders−₩8.1B−₩5.8B−₩7.5B

Balance sheet

202520242023
Total assets₩41B₩45B₩32B
Current assets₩20B₩29B₩16B
Cash and equivalents₩6.1B₩4.5B₩1.4B
Total liabilities₩24B₩26B₩20B
Current liabilities₩12B₩12B₩7.7B
Borrowings₩13B₩18B₩11B
Total equity₩17B₩18B₩12B
Shareholders' equity₩8.7B₩12B₩6.9B

Cash flow

202520242023
Cash from operations−₩4B−₩3.5B−₩6.1B
Capital spending₩4.4B₩1.4B₩1.8B
Free cash flow−₩8.3B−₩4.9B−₩8B

Consolidated where available. Amounts in won.

Also known as: S.Biomedics / 에스바이오메딕스 / 304360 / KRX:304360

Source: KRX statistical information